Clinical Trial Update: Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial update evaluating cisplatin for malignant pleural effusion in patients with non-small cell lung cancer. The current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Shantou University Medical College | Conditions: Pleural Effusion, Malignant | NA | Status: UNKNOWN